Merck (MRK) Current Assets (2009 - 2026)
Merck's Current Assets was $36.68 billion in Q2 2026, down 1.0% from $37.07 billion a year earlier but up 4.8% from the prior quarter.
Powered by 
Analysis
Merck (MRK) Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Merck came in at $43.52 billion, up 12.2% from FY2024.
- Current Assets shows a five-year compound annual growth rate of 9.4% (FY2020 to FY2025).
- In earlier years, Current Assets was $38.78 billion in FY2024 (+20.6%), $32.17 billion in FY2023 (-9.9%), $35.72 billion in FY2022 (+18.0%) and $30.27 billion in FY2021 (+9.0%).
- Quarterly Current Assets has moved between $29.98 billion (Q2 2023) and $47.56 billion (Q3 2025) over five years.
- Compared with a year earlier, Current Assets was higher in five of the last eight quarters, with growth averaging 10.6%.
- The best year-over-year quarter for Current Assets over five years was Q2 2024 (growth of 27.4%); the worst was Q4 2023 (a decline of 9.9%).
- Per Business Quant data, MRK's Current Assets in the three quarters before Q2 2026 was $35.02 billion (Q1 2026), $43.52 billion (Q4 2025) and $47.56 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 28.58 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.68 Bn |
| Mar 31, 2026 | 35.02 Bn |
| Dec 31, 2025 | 43.52 Bn |
| Sep 30, 2025 | 47.56 Bn |
| Jun 30, 2025 | 37.07 Bn |
| Mar 31, 2025 | 35.50 Bn |
| Dec 31, 2024 | 38.78 Bn |
| Sep 30, 2024 | 40.36 Bn |
| Jun 30, 2024 | 38.21 Bn |
| Mar 31, 2024 | 31.45 Bn |
| Dec 31, 2023 | 32.17 Bn |
| Sep 30, 2023 | 31.95 Bn |
| Jun 30, 2023 | 29.98 Bn |
| Mar 31, 2023 | 33.40 Bn |
| Dec 31, 2022 | 35.72 Bn |
| Sep 30, 2022 | 33.56 Bn |
| Jun 30, 2022 | 32.12 Bn |
| Mar 31, 2022 | 31.18 Bn |
| Dec 31, 2021 | 30.27 Bn |
| Sep 30, 2021 | 31.06 Bn |
API Access
Merck Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();